Venrock Healthcare Capital Partners Discloses Passive Stake in Oric Pharma

TL;DR

**Venrock just revealed a big, passive stake in Oric Pharma, signaling institutional interest.**

AI Summary

Venrock Healthcare Capital Partners III, L.P. (along with its affiliates like VHCP CO-INVESTMENT HOLDINGS III, LLC and VHCP MANAGEMENT III, LLC) has filed an initial SC 13G, indicating they are a significant passive investor in Oric Pharmaceuticals, Inc. This filing, dated January 22, 2024, shows their collective ownership of Oric's common stock. This matters to investors because it signals a notable institutional investor sees value in Oric, potentially boosting confidence, but as a passive stake, it doesn't suggest immediate strategic changes.

Why It Matters

This filing reveals a major institutional investor, Venrock Healthcare Capital Partners, has taken a significant, passive position in Oric Pharmaceuticals, which can be seen as a vote of confidence in the company's future.

Risk Assessment

Risk Level: low — This filing indicates a passive investment, which generally carries lower risk as it doesn't suggest an activist agenda or immediate disruptive changes.

Analyst Insight

A smart investor would view this as a positive signal of institutional interest, but recognize it's a passive stake, so no immediate strategic changes are implied. Further research into Oric's fundamentals and Venrock's investment thesis would be prudent.

Key Players & Entities

• Venrock Healthcare Capital Partners III, L.P. (company) — the primary reporting person and institutional investor
• Oric Pharmaceuticals, Inc. (company) — the subject company in which shares are held
• KOH, BONG (person) — a group member associated with the reporting entity
• SHAH, NIMISH (person) — a group member associated with the reporting entity
• VHCP CO-INVESTMENT HOLDINGS III, LLC (company) — a group member associated with the reporting entity
• VHCP MANAGEMENT III, LLC (company) — a group member associated with the reporting entity

Forward-Looking Statements

• Oric Pharmaceuticals, Inc. may experience a slight increase in investor confidence due to Venrock's disclosed stake. (Oric Pharmaceuticals, Inc.) — medium confidence, target: Q1 2024
• Venrock Healthcare Capital Partners III, L.P. will maintain a passive investment strategy in Oric Pharmaceuticals for the foreseeable future. (Venrock Healthcare Capital Partners III, L.P.) — high confidence, target: Q4 2024

FAQ

Key Financial Figures

• $0.0001 — Inc. (Name of Issuer) Common stock, $0.0001 par value per share (Title of Class o

Filing Documents

• tm244728d1_sc13g.htm (SC 13G) — 178KB
• 0001104659-24-009469.txt ( ) — 180KB

From the Filing

SC 13G 1 tm244728d1_sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ORIC Pharmaceuticals, Inc. (Name of Issuer) Common stock, $0.0001 par value per share (Title of Class of Securities) 68622P109 (CUSIP Number) January 22, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise CUSIP No. 68622P109 Page 2 of 17 1. Names of Reporting Persons Venrock Healthcare Capital Partners III, L.P. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (1) (b) 3. SEC Use Only 4. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 0 6. Shared Voting Power 4,428,385 (2) 7. Sole Dispositive Power 0 8. Shared Dispositive Power 4,428,385 (2) 9. Aggregate Amount Beneficially Owned by Each Reporting Person 4,428,385 (2) 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 6.6% (3) 12. Type of Reporting Person (See Instructions) PN (1) Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G. (2) Consists of (i) 609,811 shares held by Venrock Healthcare Capital Partners III, L.P.; (ii) 61,002 shares held by VHCP Co-Investment Holdings III, LLC; and (iii) 3,757,572 shares held by Venrock Healthcare Capital Partners EG, L.P. (3) This percentage is calculated based upon 67,365,553 shares of Common Stock outstanding on January 23, 2024, as set forth in the Issuer’s Registration Statement on Form S-3 filed with the Securities and Exchange Commission (the “SEC”) on January 26, 2024. CUSIP No. 68622P109 Page 3 of 17 1. Names of Reporting Persons VHCP Co-Investment Holdings III, LLC 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (1) (b) 3. SEC Use Only 4. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 0 6. Shared Voting Power 4,428,385 (2) 7. Sole Dispositive Power 0 8. Shared Dispositive Power 4,428,385 (2) 9. Aggregate Amount Beneficially Owned by Each Reporting Person 4,428,385 (2) 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 6.6% (3) 12. Type of Reporting Person (See Instructions) OO (1) Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G. (2) Consists of (i) 609,811 shares held by Venrock Healthcare Capital Partners III, L.P.; (ii) 61,002 shares held by VHCP Co-Investment Holdings III, LLC; and (iii) 3,757,572 shares held by Venrock Healthcare Capital Partners EG, L.P. (3) This percentage is calculated based upon 67,365,553 shares of Common Stock outstanding on January 23, 2024, as set forth in the Issuer’s Registration Statement on Form S-3 filed with the SEC on January 26, 2024. CUSIP No. 68622P109 Page 4 of 17 1. Names of Reporting Persons Venrock Healthcare Capital Partners EG, L.P. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (1) (b) 3. SEC Use Only 4. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 0 6. Shared Voting Power 4,428,385 (2) 7. Sole Dispositive Power 0 8. Shared Dispositive Power 4,428,385 (2) 9. Aggregate Amount Beneficially Owned by Each Reporting Person 4,428,385 (2) 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 6.6% (3) 12. Type of Reporting Person (See Instructions) PN (1) Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdin

View Full Filing

View this SC 13G filing on SEC EDGAR